|Bid||15.38 x 1200|
|Ask||15.41 x 3000|
|Day's Range||13.78 - 17.00|
|52 Week Range||1.95 - 32.29|
|Beta (5Y Monthly)||2.64|
|PE Ratio (TTM)||52.54|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Canadian weed giant Tilray (NASDAQ: TLRY) was on a tear for much of 2020. Investors have a lot to be thrilled about with Tilray, the most promising of which is its substantial international presence, which will become a game-changer as more countries legalize the recreational and medical use of cannabis. Let's investigate how Tilray can capitalize on marijuana's entry to the mainstream.
The Canadian pot stock rose amid a Reddit-fueled rally and positive earnings results from Tilray, which will merge with Aphria next quarter.
After soaring to all-time highs last month, exchange traded funds tracking cannabis stocks are coming back down to test a key support line.